# Cogent Biosciences, Inc.: Form 8-K, filed Mar 22, 2024

- Company: [Cogent Biosciences, Inc.](/companies/cogt.md) (CIK 1622229)
- Form: 8-K
- Filed: 2024-03-22
- Accepted by EDGAR: Mar 22, 2024, 08:33 ET
- Period: 2024-03-21
- Accession: 0001193125-24-074628
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1622229/000119312524074628/d796451d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1622229/000119312524074628/

## Items reported

- Item 3.02: Unregistered sale of equity
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1622229/000119312524074628/d796451d8k.htm

Filed Mar 22, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-074628. Last ingested by Listed: Nov 5, 2026, 18:48 ET. No prices; not investment advice.